Back to Journals » OncoTargets and Therapy » Volume 16

Targeted Treatment of Adults with Relapsed or Refractory Diffuse Large B-Cell Lymphoma (DLBCL): Tafasitamab in Context

Total article views   HTML views PDF downloads Totals
3,827 Dovepress* 3,053+ 108 3,161
PubMed Central* 774 191 965
Totals 3,827 299 4,126
*Since 20 July 2023
Total mentioned Facebook Delicious Reddit Twitter Others
20 0 0 0 10 10

View citations on PubMed Central and Google Scholar